» Authors » Sara Jacobs

Sara Jacobs

Explore the profile of Sara Jacobs including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 239
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jacobs S, Rotunda W, Sarris Esquivel N, Horvitz C, Ng V, Vincent A, et al.
Health Promot Pract . 2024 Dec; :15248399241302051. PMID: 39716818
Background: Diabetes affects millions of people in the United States and poses significant health and economic challenges, but it can be prevented or managed through health behavior changes. Such changes...
2.
Mendez G, Nocek J, Brambilla D, Jacobs S, Cole O, Kanter J, et al.
BMC Health Serv Res . 2024 Mar; 24(1):291. PMID: 38448911
Background: Adults with sickle cell disease (SCD) suffer early mortality and high morbidity. Many are not affiliated with SCD centers, defined as no ambulatory visit with a SCD specialist in...
3.
Hankins J, Brambilla D, Potter M, Kutlar A, Gibson R, King A, et al.
Blood Adv . 2023 Sep; 7(23):7190-7201. PMID: 37738155
Hydroxyurea reduces sickle cell disease (SCD) complications, but medication adherence is low. We tested 2 mobile health (mHealth) interventions targeting determinants of low adherence among patients (InCharge Health) and low...
4.
Lamont A, Hsu L, Jacobs S, Gibson R, Treadwell M, Chen Y, et al.
PLoS One . 2022 Nov; 17(11):e0272204. PMID: 36367870
Accruing evidence reveals best practices for how to help individuals living with Sickle Cell Disease (SCD); yet, the implementation of these evidence-based practices in healthcare settings is lacking. The Sickle...
5.
Badawy S, DiMartino L, Brambilla D, Klesges L, Baumann A, Burns E, et al.
JMIR Form Res . 2022 Oct; 6(10):e41415. PMID: 36240004
Background: Hydroxyurea therapy is effective for reducing complications related to sickle cell disease (SCD) and is recommended by National Health Lung and Blood Institute care guidelines. However, hydroxyurea is underutilized,...
6.
Phillips S, Chen Y, Masese R, Noisette L, Jordan K, Jacobs S, et al.
PLoS One . 2022 Mar; 17(3):e0265342. PMID: 35320302
Introduction: Sickle cell disease (SCD) is an inherited hemoglobinopathy that predominantly affects African Americans in the United States. The disease is associated with complications leading to high healthcare utilization rates,...
7.
Nhim K, Gruss S, Porterfield D, Jacobs S, Elkins W, Luman E, et al.
Implement Sci . 2019 Aug; 14(1):81. PMID: 31412894
Background: The National Diabetes Prevention Program (National DPP) is rapidly expanding in an effort to help those at high risk of type 2 diabetes prevent or delay the disease. In...
8.
Kahwati L, Sorensen A, Teixeira-Poit S, Jacobs S, Sommerness S, Miller K, et al.
Jt Comm J Qual Patient Saf . 2019 Jan; 45(4):231-240. PMID: 30638973
Background: The Safety Program for Perinatal Care (SPPC) seeks to improve safety on labor and delivery (L&D) units through three mutually reinforcing components: (1) fostering a culture of teamwork and...
9.
Fernandez M, Walker T, Weiner B, Calo W, Liang S, Risendal B, et al.
Implement Sci . 2018 Mar; 13(1):52. PMID: 29587804
Background: Scientists and practitioners alike need reliable, valid measures of contextual factors that influence implementation. Yet, few existing measures demonstrate reliability or validity. To meet this need, we developed and...
10.
McMillan S, Jacobs S, Wilson L, Theodoros T, Robinson G, Anderson C, et al.
BMC Psychiatry . 2017 Apr; 17(1):139. PMID: 28407747
Background: Antipsychotics are recognised as a critical intervention for schizophrenia and bipolar disorder. Guidelines globally endorse the routine practice of antipsychotic monotherapy, at the minimum effective dose. Even in treatment-resistant...